Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA)

CUSIP: 140755109

Q2 2021 13F Holders as of 30 Jun 2021

Holder snapshot 7 signals
Share change
-250,649
Put/Call ratio
123%
SEC-reported price per share
$14.27
Number of holders
162
Value change
-$29,484,537
Number of buys
88
Open additional details 1 more signal available
Number of sells
78
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
54,790,889

Security key

140755109

Report period

Q2 2021

Institutions

162

Top holders

10

Ownership snapshot

Top reported holders of CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F Lead comparable stake: 6.7% Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. leads the comparable SEC ownership view at 6.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock Finance, Inc. 6.7%
FARALLON CAPITAL MANAGEMENT LLC 4.5%
PRICE T ROWE ASSOCIATES INC /MD/ 4.2%
VANGUARD GROUP INC 4.1%
FIRST MANHATTAN CO. LLC. 4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
6.7%
$80,042,000
3,686,965 shares
31 Mar 2021
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
13F
4.5%
$53,515,000
2,465,000 shares
31 Mar 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
4.2%
$49,918,000
2,299,299 shares
31 Mar 2021
VANGUARD GROUP INC
13F
Company
13F
4.1%
$48,919,000
2,253,247 shares
31 Mar 2021
FIRST MANHATTAN CO. LLC.
13F
Company
13F
4%
$47,096,000
2,169,351 shares
31 Mar 2021
Chescapmanager LLC
13F
Company
13F
2.4%
$28,540,000
1,314,603 shares
31 Mar 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
162
Shares
29,619,793
Rows available
162
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
156
Q2 2021 holders
162
Holder diff
6
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 value Q2 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .